Influence of calcium antagonists on the antitumor activity and the cardiac toxicity of doxorubicin in the rat.
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D004317:Doxorubicin / Q000627:therapeutic use* / Q000633:toxicity; D005260:Female; D005444:Flunarizine / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D009206:Myocardium / Q000473:pathology*; D051381:Rats; D011919:Rats, Inbred Strains; D014268:Trifluoperazine / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology*
D014268:Trifluoperazine; D004317:Doxorubicin; D014700:Verapamil; D005444:Flunarizine